MONTREAL, Dec. 7 /CNW Telbec/ - Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) wishes to correct its press release dated November 26, 2009 which stated that the Board of Directors had granted stock options to nine directors and officers in respect of an aggregate of 8,644,375 common shares. In fact, stock options were granted to eight directors and officers in respect of an aggregate of 8,044,375 common shares. In addition, the press release stated that Sonomax had granted stock options to an aggregate of 20 employees and consultants, including one investor-relations consultant, in respect of an aggregate of 5,098,750 common shares. In fact, stock options were granted to an aggregate of 20 employees and consultants, including one investor-relations consultant, in respect of an aggregate of 4,998,750 common shares. The stock options were granted under Sonomax's 2001 Stock Option Plan.
The exercise price of the stock options is $0.10 per share. They expire five years from the date of grant.
About the New Sonomax:
Sonomax is an R&D and licensing company of in-ear technologies. The Company's patented instant custom-fitting earpieces deliver the most comfortable sound-enhancing earpieces in the world. This unique technology enables a wide range of applications such as earphones for the music and gaming markets, hearing protection for military and industrial applications, affordable hearing aids and the ever-expanding Bluetooth(TM) headset market.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Sonomax Technologies Inc.
For further information: For further information: Nick Laperle, President and CEO, Sonomax Hearing Healthcare Inc., (514) 932-2674, email@example.com